Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.
Ginkgo Bioworks Holdings, Inc. ((DNA)) has held its Q4 earnings call. Read on for the main highlights of the call. Ginkgo Bioworks’ latest earnings call struck a cautiously optimistic tone as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results